1. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot L, Glinoer D, Mandel SJ, Stagnaro-Green A: Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 92 (8) (Supplement): S1-S47, 2007

 

2. Dworkin HJ, Jacquez JA, Beierwaltes WH: Relationship of iodine ingestion to iodine excretion in pregnancy. J Clin Endocrinol Metab 26:1329, 1966

3. Glinoer D, De Nayer P, Bourdoux, et al: Regulation of maternal thyroid function during pregnancy. J Clin Endocrinol Metab 71:276, 1990

4. Glinoer D, Delange F, Laboureur I, De Nayer P: Maternal and neonatal thyroid function at birth in an area with of marginally low iodine intake. J Clin Endocrinol Metab 75:800, 1992

5. Burrow GN: Thyroid function and hyperfunction during gestation. Endocr Rev 14:194, 1993

6. Glinoer D: The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18:404, 1997

7. Liberman CS, Pino SC, Lieh Fang S, Braverman LE, Emerson CH: Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab 83:3545, 1998

8. Halnan KE: The radioiodine uptake of the human thyroid in pregnancy. Clin Sci 17:281, 1958

9. Crooks J, Tulloch MI, Turnbull AC, et al: Comparative incidence of goitre in pregnancy in Iceland and Scotland. Lancet 2:625, 1969

10. Glinoer D, Lemone M: Goiter and pregnancy: a new insight into an old problem. Thyroid 2:65, 1992

11. Glinoer D, De Nayer P, Delange F, et al: A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab 80:258, 1995

12. Levy RP, Newman DM, Rejali LS, Barford DA: The myth of goiter in pregnancy. Am J Obstet Gynecol 137:701, 1980

13. Nelson M, Wickus GG, Caplan RH, Beguin EA: Thyroid gland size in pregnancy: an ultrasound and clinical study. J Reproduct Med 32:888, 1987

14. Hershman JM: Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:249, 2004 

15. Merz WE: Biosynthesis of human chorionic gonadotropin: a review. Eur J Endocrinol 135:269, 1996

16. Smits G, Govaerts C, Nubourgh I, Pardo L, Vassart G, Costagliola S: Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Molec Endocrinol 16:722, 2002

17. Hershman JM, Lee HY, Sugawara M, et al: Human chorionic gonadotropin stimulates iodide uptake, adenylate cyclase, and deoxyribonuceic acid synthesis in cultured rat thyroid cells. J Clin Endocrinol Metab 67:74, 1988

18. Hershman JM: Role of human chorionic gonadotropin as a thyroid stimulator. J Clin Endocrinol Metab 74:258, 1992

19. Pekonen F, Alfthan H, Stenman UH, Ylikorkala O: Human chorionic gonadotropin (hCG) and thyroid function in early pregnancy: Circadian variation and evidence for intrinsic thyrotropic activity of hCG. J Clin Endocrinol Metab 66:853, 1988

20. Harada A, Hershman JM, Reed AW, et al: Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab 48:793, 1979

21. Kimura M, Amino N, Tamaki H, et al: Physiologic thyroid activation in normal early pregnancy is induced by circulating hCG. Obstet Gynecol 75:775, 1990

22. Arturi F, Presta I, Scarpelli D, et al: Stimulation of iodide uptake by human chorionic gonadotropin in FRTL-5 cells: effects on sodium/iodide symporter gene and protein expression. Eur J Endocrinol 147:655, 2002 

23. Ballabio M, Poshyachinda M, Ekins RP: Pregnancy-induced changes in thyroid function: Role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab 73:824, 1991

24. Glinoer D, De Nayer P, Robyn C, et al: Serum levels of intact human chorionic gonadotropin (hCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 16:881, 1993

25. Guillaume J, Schussler GC, Goldman J: Components of the total serum thyroid hormone concentrations during pregnancy: high free thyroxine and blunted thyrotropin (TSH) response to TSH-releasing hormone in the first trimester. J Clin Endocrinol Metab 60:678, 1985

26. Weeke J, Dykbjaer L, Granlie K, et al: A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol 101:531, 1982

27. Chan BY, Swaminathan R: Serum thyrotropin concentration measured by sensitive assays in normal pregnancy. Br J Obstet Gynaecol 95:1332, 1988

28. Yamamoto T, Amino N, Tanizawa O, et al: Longitudinal study of serum thyroid hormones, chorionic gonadotrophin during and after normal pregnancy. Clin Endocrinol 10:459, 1979

29. Ylikorkala O, Kivinen S, Reinila MI: Serial prolactin and thyrotropin responses to thyrotropin-releasing hormone throughout normal human pregnancy. J Clin Endocrinol Metab 48:288, 1979

30. Yoshikawa N, Nishikawa M, Horimoto M, et al: Thyroid-stimulating activity in sera of normal pregnant women. J Clin Endocrinol Metab 69:891, 1989

31. Pacchiarotti A, Martino E, Bartalena L, et al: Serum thyrotropin by ultrasensitive immunoradiometric assay and serum free thyroid hormones in pregnancy. J Endocrinol Invest 9:185, 1986

32. Glinoer D: The thyroid in pregnancy: a European perspective. Thyroid Today 18:1, 1995

33. Kraiem Z, Lahat N, Sadeh O, et al: Desialylated and deglycosylated human chorionic gonadotropin are superagonists of native human chorionic gonadotropin in human thyroid follicles. Thyroid 7:783, 1997

34. Norman RJ, Green-Thompson RW, Jialal I, et al: Hyperthyroidism in gestational trophoblastic neoplasia. Clin Endocrinol 15:395, 1981

35. Nagataki S, Mizuno M, Sakamoto S, et al: Thyroid function in molar pregnancy. J Clin Endocrinol Metab 44:254, 1977

36. Berghout A, Endert E, Wiersinga WM, Touber JL: The application of an immunoradiometric assay of plasma thyrotropin (TSH-IRMA) in molar pregnancy. J Endocrinol Invest 11:15, 1988

37. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG: Hyperemesis gravidarum, a literature review. Hum Reprod Update 11:527, 2005

38. Al-Yatama M, Diejomaoh M, Nandakumaran M, et al: Hormone profile of Kuwaiti women with hyperemesis gravidarum. Arch Gynecol Obstet 266:218, 2002    

39. Tan JY, Loh KC, Yeo GS, Chee YC: Transient hyperthyroidism of hyperemesis gravidarum. Brit J Obstet Gynaecol 109:683, 2002

40. Kirshon B, Lee W, Cotton DB: Prompt resolution of hyperthyroidism and hyperemesis gravidarum after delivery. Obstet Gynecol 71:1032, 1988

41. Goodwin TM, Montoro M, Mestman JH: Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167:648, 1992

42. Goodwin TM, Montoro M, Mestman JH: The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333, 1992

43. Lao TT, Chin KH, Chang AMZ: The outcome of hyperemetic pregnancies complicated by transient hyperthyroidism. Aust NZ J Obstet Gynaecol 27:99, 1987

44. Dozeman R, Kaiser FE, Cass O, Pries J: Hyperthyroidism appearing as hyperemesis gravidarum. Arch Int Med 143:2202, 1983

45. Goodwin TM, Hershman JM: Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol 40:32, 1997

46. Glinoer D: Thyroid hyperfunction during pregnancy. Thyroid 8:859, 1998

47. Mori M, Amino N, Tamaki H, et al: Morning sicknesss and thyroid function in normal pregnancy. Obstet Gynecol 72:355, 1988

48. Bouillon R, Naessens M, Van Assche FA, et al: Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol 143:922, 1982

49. Yoshimura M, Hershman JM, Pang XP, Berg L, Pekary AE: Activation of the thyrotropin (TSH) receptor by human chorionic gonadotropin and luteinizing hormone in Chinese hamster ovary cells expressing functional human TSH receptors. J Clin Endocrinol Metab 77:1009, 1993

50. Yoshimura M, Hershman JM: Thyrotropic action of human chorionic gonadotropin. Thyroid 5:425, 1995

51. Jordan V, Grebe SK, Cooke RR, et al: Acidic forms of chorionic gonadotrophin in European and Samoan women are associated with hyperemesis gravidarum and may be thyrotrophic. Clin Endocrinol 50:619, 1999

52. Glinoer D, Gershengorn MC, Dubois A, et al: Stimulation of thyroxine-binding globulin synthesis by isolated rhesus monkey hepatocytes after in vivo -estradiol administration. J Clin Endocrinol Metab 100:807, 1977

53. Ain KB, Mori Y, Refetoff S: Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab 65:689, 1987

54. Ain KB, Refetoff S: Relationship of oligosaccharide modification to the cause of serum thyroxine-binding globulin excess. J Clin Endocrinol Metab 66:1037, 1988

55. Refetoff S: Inherited thyroxine-binding globulin abnormalities in man. Endocr Rev 10:275, 1989

56. Bartalena L: Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 11:47, 1990

57. Zigman JM, Cohen SE, Garber JR: Impact of thyroxine-binding globulin on thyroid hormone economy during pregnancy. Thyroid 13:1169, 2003

58. Glinoer D: Increased TBG during pregnancy and increased hormonal requirements. Thyroid (letter to the Editor) 14:179, 2004

59.  Burrow GN, Fisher DA, Larsen PR: Mechanisms of disease: Maternal and fetal thyroid function. N Engl J Med 331:1072, 1994

60. Mandel SJ, Larsen PR, Seely EW: Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Eng J Med 323:91, 1990

61. Kaplan MM: Monitoring thyroxine treatment during pregnancy. Thyroid 2:147, 1992

62. Larsen PR: Monitoring thyroxine treatment during pregnancy. Thyroid 2:153, 1992

63. Dowling JT, Appleton WG, Nicoloff JT: Thyroxine turnover during human pregnancy. J Clin Endocrinol Metab 27:1749, 1964

64. Smallridge RC, Glinoer D, Hollowell JG, Brent G: Thyroid function inside and outside of pregnancy: what do we know and what don’t we know? Thyroid 15:54, 2005

65. Demers LM, Spencer CA: Laboratory support for the diagnosis and monitoring of thyroid disease. Website of the National Academy of Clinical Biochemistry. NACB laboratory medicine practice guidelines (http://www.nacb.org/lmpg/main.stm)   

66. Soldin OP, Tractenberg RA, Hollowell JG, et al: trimester-specific changes in maternal thyroid hormone, thyrotropin and thyroglobulin concentrations during pregnancy – Trends and associations across trimesters in iodine sufficiency. Thyroid 14:1084, 2004

67.    Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J: Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 17:303, 2007

68. Osathanondh R, Tulchinsky D, Chopra IJ: Total and free thyroxine and triiodothyronine in normal and complicated pregnancy. J Clin Endocrinol Metab 42:98, 1976

69.    Sapin R, D’Herbomez M, Schlienger JL: Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab 50:581, 2004

70.    Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR: Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3, 2003

71.    Kurioka H, Takahashi K, Miyazaki K: Maternal thyroid function during pregnancy and puerperal period. Endocrine J 52:587, 2005

72. Panesar NS, Li CY, Rogers MS: Reference intervals of thyroid hormones in pregnant Chinese women. Ann Clin Biochem 38:329, 2001

73. Haddow JE, Knight GJ, Palomaki GE, et al: The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen 11:170, 2004

74.    Stricker RT, Echenard M, Eberhart R, Chevailler M-C, Perez V, Quinn FA, Stricker RN: Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 157:509, 2007

75. Dashe JS, Casey BM, Wells CE, McIntire DD, Byrd EW, Leveno KJ, Cunningham FG: Thyroid stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 106:753, 2005

76. Roti E, Fang SL, Green K, et al: human placenta is an active site of thyroxine and 3,3',5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab 53:498, 1981

77. Roti E, Gnudi A, Braverman LE: The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4:131, 1983

78. Hidal JT, Kaplan MM: Characteristics of thyroxine 5'-deiodination in cultured human placental cells. J Clin Invest 76:947, 1985

79. Burman KD, Read J, Dimond RC, et al: Measurements of 3,3',5'-triiodothyronine (reverse T3), 3,3'-L-diiodothyronine, T3, and T4 in human amniotic fluid and in cord and maternal serum. J Clin Endocrinol Metab 43:1351, 1976

80. El-Zaheri MM, Vagenakis AG, Hinerfeld L, et al: Maternal thyroid function is the major determinant of amniotic fluid 3,3',5'-triiodothyronine in the rat. J Clin Invest 67:1126, 1981

81. Landau H, Sack J, Frucht H, et al: Amniotic fluid 3,3',5'-triiodothyronine in the detection of congenital hypothyroidism. J Clin Endocrinol Metab 50:799, 1980

82. Meinhold H, Dudenhausen JW, Wenzel KW, Saling E: Amniotic fluid concentrations of 3,3',5'-triiodothyronine (reverse T3), 3,3'-diiodothyronine, 3,5,3'-triiodothyronine (T3) and thyroxine (T4) in normal and complicated pregnancy. Clin Endocrinol 10:355, 1979

83. Vulsma T, Gons MH, De Vijlder JMM: Maternal fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid dysgenesis. N Engl J Med 321:13, 1989

84. Contempre B, Jauniaux E, Calvo R, et al: Detection of thyroid hormones in human embryonic structures during the first trimester of pregnancy. J Clin Endocrinol Metab 77:1719, 1993

85. Calvo RM, Jauniaux E, Gulbis B, et al: Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87:1768, 2002

86. Glinoer D, Delange F: The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 10:871, 2000

87. Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85:3975, 2000

88. Glinoer D: The thyroid gland and pregnancy: Iodine restriction and goitrogenesis revealed. Thyroid International 5:1, 1994

89. Glinoer D: Maternal and fetal impact of chronic iodine deficiency. Clin Obstet Gynecol 40:102, 1997

90. Glinoer D: Maternal and neonatal thyroid function in mild iodine deficiency. In: Nauman J, Glinoer D, Braverman LE, Hostalek U (Editors). The Thyroid and Iodine. Stuttgart, New York, Schattauer, pp 129-143, 1996

91. Glinoer D: Pregnancy and iodine. Thyroid 11:471, 2001

92. Berbel P, Obregon MJ, Bernal J, Escobar del Rey F, Morreale de Escobar G: Iodine supplementation during pregnancy: a public health challenge. Trends Endocrinol Metab 18:338, 2007

93. WHO: Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. Second Edition, 2001

94.    ICCIDD: Iodine requirements in pregnancy and infancy. IDD Newsletter 23 (N°1), 1-2, 2007 

95. Glinoer D: The importance of iodine nutrition during pregnancy. Public Health Nutrition 10:1542, 2007

96.    Report of a WHO Technical Consultation on prevention and control of iodine deficiency in pregnancy, lactation, and in children less than 2 years of age (Geneva, 24-26 January 2005) (de Benoist B, Delange F, Editors). Public Health Nutrition (Special Issue) 10 (12A):1527-1611, 2007

97. Caron P, Hoff M, Bazzi S, et al: Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid 7:749, 1997

98. Kung AWC, Lao TT, Chau MT, Tam SCF, Low LCK: Goitrogenesis during pregnancy and neonatal hypothyroxinemia in a borderline iodine sufficient area. Clin Endocrinol 53:725, 2000

99. Nohr SB, Laurberg P, Borlum K-G, et al: Iodine deficiency in pregnancy in Denmark: regional variations and frequency of individual iodine supplementation. Acta Obstet Gynecol Scand 72:350, 1993

100. Smyth PP, Hetherton AM, Smith DF, Radcliff M, O'Herlihy C: Maternal iodine status and thyroid volume during pregnancy: correlation with neonatal iodine intake. J Clin Endocrinol Metab 82:2840, 1997

101. Vermiglio F, Lo Presti VP, Castagna MG, et al: Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders. Thyroid 9:19, 1999

102.  Antonangeli L, Maccherini D, Cavaliere R, et al: Comparison of two different doses of iodide in the prevention of gestational goiter in marginal iodine deficiency: a longitudinal study. Eur J Endocrinol 147:29, 2002

103. Chaouki ML, Benmiloud: Prevention of iodine disorders by oral administration of lipiodol during pregnancy. Eur J Endocrinol 130:547, 1994

104. Liesenkotter KP, Gopel W, Bogner U, Stach B, Gruters A: Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 134:443, 1996

105.  Nohr SB, Laurberg P: Opposite variations in maternal and neonatal thyroid function induced by iodine supplementation during pregnancy. J Clin Endocrinol Metab 85:623, 2000

106. Pedersen KM, Laurberg P, Iversen E, et al: Amelioration of some pregnancy-associated variations in thyroid function induced by iodine supplementation. J Clin Endocrinol Metab 77:1078, 1993

107. Romano R, Jannini EA, Pepe M, et al: The effects of iodoprophylaxis on thyroid size during pregnancy. Am J Obstet Gynecol 164:482, 1991

108. Silva JE, Silva S: Interrelationships among thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid-stimulating hormone in iodine-deficient pregnant women and their offspring: effects of iodine supplementation. J Clin Endocrinol Metab 52:671, 1981

109. Stilwell G, Reynolds PJ, Parameswaran V, Blizzard L, Greenaway TM, Burgess JR: The influence of gestational stage on urinary iodine excretion in pregnancy. J Clin Endocrinol Metab 93:1737, 2008

110. Ainy E, Ordookhani A, Hedayati M, Azizi F: Assessment of intertrimester and seasonal variations of urinary iodine concentration during pregnancy in an iodine-replete area. Clin Endocrinol 67:577, 2007

111. Smyth PP, Smith DF, Sheehan S, Higgins M, Burns R, O’ Herlihy C: Short-term changes in maternal and neonatal urinary excretion. Thyroid 17:219, 2007

112. Dorey CM, Zimmermann MB: Reference values for spot urinary iodine concentrations in iodine-sufficient newborns using a new pad collection method. Thyroid 18:347, 2008         

113. Delange F, de Benoist B, Pretell E, Dunn J: Iodine deficiency in the world: where do we stand at the turn of the century. Thyroid 11:437, 2001

114. Delange F, Eastman CJ, Hostalek U, Butz S, Smyth PP: The story of the ThyroMobil. Thyroid International N°1, 3-13, 2007

115. Als C, Keller A, Minder C, Haldimann M, Gerber H: Age- and gender-dependent urinary iodine concentrations in an area-covering population sample from the Bernese region in Switzerland. Europ J Endocrinol 143:629, 2000

116. Brander L, Als C, Buess H, et al.: Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland. J Endocrinol Invest 26:389-396, 2003

117. Sack J, Goldstein A, Charpak N, et al.: Postpartum maternal hyperthyrotropinemia in an area in which iodine supplementation is required. Thyroid 13:959-964, 2003

118. Ciardelli R, Haumont D, Gnat D, et al: The nutritional iodine supply of belgian neonates is still insufficient. Europ J Pediatr 161:519, 2002

119. The Public Health Committee of the American Thyroid Association: Iodine supplementation for pregnancy and lactation – United States and Canada: recommendations of the American Thyroid Association. Thyroid 16:949, 2006

120. Hollowell JG, Staehling NW, Hannon WH, et al: Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from national health and nutrition examination surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 83:3401, 1998

121. Caldwell JK, Jones R, Hollowell JG: Urinary iodine concentrations: United States National Health and Nutrition Examination Survey 2001-2002. Thyroid 15:692, 2005

122. Dunn JT: What is happening to our iodine (Editorial). J Clin Endocrinol Metab 83:3398, 1998

123. Dunn JT, Delange F: Damaged reproduction: the most important consequence of iodine deficiency. J Clin Endocrinol Metab 86:2360, 2001

124. Glinoer D (Guest Editorial): Iodine nutrition requirements during pregnancy. Thyroid 16:947, 2006

125. Sullivan KJ: Letter to the Editor. Thyroid 17:483, 2007      

126. Glinoer D: The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:133, 2004

127. Glinoer D: Feto-maternal repercussions of iodine deficiency during pregnancy. Annales d’Endocrinologie (Paris) 64:37, 2003

128. Glinoer D: What happens to the normal thyroid during pregnancy? Thyroid 9:631, 1999

129. Brander A, Kivisaari L: Ultrasonography of the thyroid during pregnancy. J Clin Ultrasound 17:403, 1989

130. Glinoer D, Lemone M, Bourdoux P, et al: Partial reversibility during late postpartum of thyroid abnormalities associated with pregnancy. J Clin Endocrinol Metab 74:453, 1992

131. Rotondi M, Amato G, Biondi B, et al: Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. J Clin Endocrinol Metab 85:4534, 2000

132. Knudsen N, Bülow I, Laurberg P, et al: Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Europ J Endocrinology 146:39, 2002

133. Glinoer D, Demeester R, Lemone M, et al.: Acute increase in goiter size during a normal pregnancy: an exceptional case report. Thyroid 13:881, 2003

134. Aloumanis K, Mavroudis K, Vassiliou I, Arkadopoulos N, et al: Urgent thyroidectomy for acute airway obstruction caused by a goiter in a euthyroid pregnant woman. Thyroid 16:85, 2006

135. Delange F, Lecomte P: Iodine supplementation – Benefits outweigh risks. Drug Safety 2:89, 2000

136. Delange F, Benker G, Caron P, et al: Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficicency. Eur J Endocrinol 136:180, 1997

137. Delange F, Van Onderbergen A, Shabana W, et al: Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency: the case of Belgium. Eur J Endocrinol 143:189, 2000

138.  Ivanova RB, Kirilov G, Ivanova LB, Lozanov BS: Evaluation of the thyroid status of pregnant women under supplementation with iodized salt. J Endocrinol Invest 25 (suppl. to N° 7):91, 2002

139. Delange F, Bürgi H, Chen ZP, Dunn JT: World status of monitoring of iodine deficiency disorders control programs. Thyroid 12:915, 2002

140.  Dunn JT: The use of iodized oil and other alternatives for the elimination of iodine deficiency disorders. In: the Conquest of Iodine Deficiency Disorders (Hetzel BS, Pandav CS, Editors).  New Delhi: Oxford University Press Publications; pp 108-117, 1994

141.  Thilly CH, Delange F, Lagasse R, et al: Fetal hypothyroidism and maternal thyroid status in severe endemic goiter.  J Clin Endocrinol Metab 47:354, 1978

142. Delange F: Optimal iodine nutrition during pregnancy, lactation and the neonatal period. Int J Endocrinol Metab 2:1, 2004

143. Zimmermann MB, Aeberli I, Torresani T, Bürgi H: a small increase in salt iodination improves iodine nutrition in children and pregnant women. Am J Clin Nutrition 82:388, 2005

144. Andersson M, Takkouche B, Egli I, et al: Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull WHO 83:518, 2005 

145. Imaizumi M, Pritzker A, Kita M, et al: Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. J Clin Endocrinol Metab 142:823, 2001

146. Sridama V, Pagini F, Yang SL, et al: Decreased level of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med 307:352, 1982

147. Stagnaro-Green A, Roman SH, Cobin RH, et al: A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum dysfunction. J Clin Endocrinol Metab 74:645, 1992

148. Bech K, Hoier-Madsen M, Feldt-Rasmussen U, et al: Thyroid function in insulin-dependent diabetes mellitus during and after pregnancy. Acta Endocrinol 124:534, 1991

149. DeGroot LJ, Quintans J: The causes of autoimmune thyroid disease. Endocr Rev 10:537, 1989

150. Amino N, Miayi K, Onishi T, et al: Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab 42:296, 1976

151. Amino N, Miayi K, Kuro R, et al: Transient postpartum hypothyroidism: fourteen cases with autoimmune thyroiditis. Ann Intern Med 87:155, 1977

152. Amino N, Mori H, Iwatani Y, et al: High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 306:849, 1982

153. Jansson R, Bernander S, Karlsson A, et al: Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab 58:681, 1984

154. Bech K, Hertel J, Rasmussen NG, et al: Effect of maternal thyroid autoantibodies and post-partum thyroiditis on the fetus and neonate. Acta Endocrinol 125:146, 1991

155. McKenzie JM, Zakarija M: The clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab 69:1093, 1989

156. Mc Kenzie JM, Zakarija M: Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2:155, 1992

157. Roti E, Emerson CH: Postpartum thyroiditis. J Clin Endocrinol Metab 74:3, 1992

158. Rasmussen NG, Hornnes PJ, Hoier-Madsen M, et al: Thyroid size and function in healthy pregnant women with thyroid autoantibodies: Relation to development of postpartum thyroiditis. Acta Endocrinol 123:395, 1990

159. Zakarija M, McKenzie JM: Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57:1036, 1983

160. Jansson R, Totterman TH, Sallstrom J, Dahlberg PA: Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 58:942, 1984

161.  Thonneau P, Marchand S, Tallec A, et al: Incidence and main causes of infertility in a resident population (1.850.000) of three French regions (1988-1989). Hum Reprod 6:811, 1991

162. Dosiou C, Giudice LC: Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocrine Rev 26:44, 2005

163. Poppe K, Velkeniers B: Female infertility and the thyroid. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:153, 2004

164.  Poppe K, Glinoer D, Van Steirteghem A, et al: Thyroid dysfunction and autoimmunity in infertile women. Thyroid 12:997, 2002

165. Poppe K, Glinoer D, Tournaye H, et al: Assisted reproduction and thyroid immunity: an unfortunate combination? J Clin Endocrinol Metab 88:4149, 2003

166. Poppe K, Glinoer D, Van Steirteghem A, et al: Increased thyroid autoimmunity but not thyroid dysfunction in infertile women. A comment by Utiger RD in Clinical Thyroidology 15:2, 2003

167. Poppe K, Velkeniers B, Glinoer D: Thyroid disease and female reproduction. Clin Endocrinol 66:309, 2007

168. Trummer H, Ramschak-Schwarzer S, Haas J, et al: Thyroid hormones and thyroid antibodies in infertile males. Fertil Steril 76:254, 2001

169. Krassas GE, Perros P: Thyroid disease and male reproductive function. J Endocrinol Invest 26:372, 2003

170. Krassas GE, Pontikides N: Male reproductive function in relation with thyroid alterations. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:183, 2004

171. Krassas GE, Tziomalos K, Papadopoulou F, Pontikides N, Perros P: Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab 93:1815, 2008

172. Wilcox AJ, Weinberg CR, O’Conner JF, et al: Incidence of early loss of pregnancy. N Engl J Med 319:189, 1988

173. Fausett MB, Branch DW: Autoimmunity and pregnancy loss. Sem Reprod Med 18:379, 2000

174. Li TC, Makris M, Tomsu M, et al: Recurrent miscarriage: aetiology, management and prognosis. Eur Soc Hum Reprod Embryol 8:463, 2002  

175. Stagnaro-Green A, Roman SH, Cobin RH, et al: Detection of at-risk pregnancy by means of highly sensitive assays for thyroid antibodies. JAMA 264:1422, 1990

176. Glinoer D, Fernandez Soto ML, Bourdoux P, et al: Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercussions. J Clin Endocrinol Metab 73:421, 1991

177. Poppe K, Glinoer D: Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update 9:149, 2003

178. Stagnaro-Green A, Glinoer D: Thyroid autoimmunity and the risk of miscarriage. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:167, 2004

179. Prummel MF, Wiersinga WM: Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150:751, 2004

180. Roberts J, Jenkins C, Wilson R, Pearson C, et al: Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodies. Eur J Endocrinol 134:84, 1996

181. Matalon ST, Blank M, Ornoy A, Shoenfeld Y: The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 45:72, 2001

182. Matalon ST, Blank M, Levy Y, Carp HJ et al: The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod 18:1094, 2003

183. Bagis T, Gokcel A, Saygili ES: Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid 11:1049, 2001

184. Muller AF, Verhoeff A, Mantel MJ, Berghout A: Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertil Steril 71:30, 1999

185. Abramson J, Stagnaro-Green A: Thyroid antibodies and fetal loss: an evolving story. Thyroid 11:57, 2001

186. Bussen S, Steck T, Dietl J: Increased prevalence of thyroid antibodies in women with a history of recurrent in-vitro fertilization failure. Human Reprod 15:545, 2000

187. Dendrinos S, Papasteriades C, Tarassi K, et al: Thyroid autoimmunity in patients with recurrent spontaneous abortion. Gynecol Endocrinol 14:270, 2000

188. Glinoer D: Thyroid immunity, thyroid dysfunction, and the risk of miscarriage (Editorial). Am J Reprod Immunol 43:202, 2000

189. Netto S, Medina Coeli C, et al: Thyroid autoimmunity is a risk factor for miscarriage. Am J Reprod Immunol 52:312, 2004

190. Poppe K, Velkeniers B, Glinoer D: The role of thyroid autoimmunity in fertility and prengnacy. Nature Clin Pract Endocrinol Metab 4:394, 2008

191. Kim CH, Chae HD, Kang BM, Chang YS: Influence of antithyoid antibodies in euthyroid women on in vitro fertilization embryo transfer outcome. Am J Reprod Immunol 40:2, 1998

192. Negro R, Mangieri T, Coppola L, et al: Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 20:1529, 2005

193. Singh A, Dantas ZN, Stone SC, et al: Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril 63:277, 1995

194. Kutteh WH, Schoolcraft WB, Scott RT Jr: Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod 14:2886, 1999

195. Kutteh WH, Yetman DL, Carr AC, et al: Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 71:843, 1999

196. Negro R, Formoso G, Coppola L, Presicce G, et al: Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J Endocrinol Invest 30:3, 2007  

197. Geva E, Vardinon N, Lessing JB, et al: Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programme. Hum Reprod 11:1627, 1996

198. Kiprov DD, Nachtigall RD, Weaver RC, et al: The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 36:228, 1996

199. Sher G, Zouves C, Feinman M, et al: The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 39:223, 1998

200. Stricker RB, Steinleitner A, Bookoff CN, et al: Successful treatment for immunological abortion with low-dose intravenous immunoglobulin. Fertil Steril 73:536, 2000

201. Vaquero E, Lazzarin N, De Carolis C, et al: Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutic approach. Am J Reprod Immunol 43:204, 2000

202. Negro R, Formoso G, Mangieri T, Pezzarossa A, et al: Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91:2587, 2006

203. Glinoer D: Miscarriage in women with positive anti-TPO antibodies: is thyroxine the answer (Editorial). J Clin Endocrinol Metab 91:2500, 2006

204. Arojoki M, Jokimaa V, Juuti A, et al: Hypothyroidism among infertile women in Finland. Gynecol Endocrinol 14:127, 2000

205. Vanderpump MP, Tunbridge WM, French JM, et al: The incidence of thyroid disorders in a community: a twenty-year follow-up of the Whickam survey. Clin Endocrinol 43:55, 1995

206. Gerstein HC: Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med 118:419, 1993

207. Olivieri A, Valensise H, Magnani F, et al: High frequency of antithyroid antibodies in pregnant women at increased risk of gestational diabetes mellitus. Europ J Endocrinol 143:741, 2000

208. Glinoer D: The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol Metab 9: 403, 1998

209. Glinoer D, Rihai M, Grün JP, Kinthaert J: Risk of subclinical hypothyroidism in pregnant women with autoimmune thyroid disorders. J Clin Endocrinol Metab 79:197, 1994

210. Klein RZ, Haddow JE, Faix JD, et al: Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 35:41, 1991

211. Allan WC, Haddow JE, Palomaki GE, et al: Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 7:127, 2000

212. Glinoer D: Thyroidal and immune adaptation to pregnancy: focus on maternal hypo- and hyperthyroidism. In: Pirags V, Lazarus J, Butz S (Eds) The Thyroid and Autoimmunity. Georg Thieme Verlag; Stuttgart-New York (In press, 2008)

213. Casey BM, Dashe JS, Spong CY, et al: Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 109:1129, 2007  

214.  Gallas PR, Stolk RP, Bakker K, et al: Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur J Endocrinol 147:443, 2002

215. Jovanovic-Peterson I, Peterson CM: De novo clinical hypothyroidism in pregnancies complicated by type I diabetes. Am J Obstet Gynecol 159:442-446, 1988

216. Caturegli P, Newschaffer C, Olivi A, et al: Autoimmune hypophysitis. Endocr Rev 26:599, 2005

217. Ginsberg J, Walfish PG, Rafter DJ, et al: Thyrotrophin blocking antibodies in the sera of mothers with congenitally hypothyroid infants. Clin Endocrinol 25:189, 1986

218. Bogner U, Grüters A, Sigle B, et al: Cytotoxic antibodies in congenital hypothyroidism. J Clin Endocrinol Metab 68:671, 1989

219. Tamaki H, Amino N, Aozasa M, et al: Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis. Am J Perinatol 6:296, 1989

220. Brown RS, Keating P, Mitchell E: Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism. J Clin Endocrinol Meteb 70:1341, 1990

221. Ueta Y, Fukui H, Murakami H, et al: Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves’ disease in late pregnancy. Thyroid 9:179, 1999

222. Leung AS, Millar LK, Koonings PP, et al: Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 81:349, 1993

223. Fukushi M, Honma K, Fujita K (Letter to the Editor). New Engl J Med 341:2016, 1999

224. Haddow JE, Palomaki GE, Allan WC, et al: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549, 1999

225. Abalovich M, Gutierrez S, Alcaraz G, et al: Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12:63, 2002

226. Sieiro Netto S, Medina Coeli M, Micmacher E, Mamede Da Costa S, et al: Influence of thyroid autoimmunity and maternal age on the risk of miscarriage. Am J Reprod Immunol 52:312-316, 2004

227. Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO: The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 15:351, 2005

228. Glinoer D: Management of hypo- and hyperthyroidism during pregnancy. Growth Hormone & IGF Research 13:45, 2003

229. Mandel SJ: Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:213, 2004

230. Spong CY (Editorial): Subclinical hypothyroidism: should all pregnant women be screened? Obstet Gynecol 105:237, 2005

231.  Klintschar M, Schwaiger P, Mannweiler S, et al: Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 86:2494, 2001

232. Ando T, Imaizumi M, Graves P, et al: Intrathyroidal fetal microchimerism in Graves’ disease. J Clin Endocrinol Metab  87:3315, 2002

233. Imaizumi M, Pritsker A, Unger P, Davies TF: Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 143:247, 2002

234. Ando T, Davies TF: Self-recognition and the role of fetal microchimerism. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:197, 2004

235. Renné C, Ramos Lopez E, Steimle-Grauer SA, et al: Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosome immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto’s thyroiditis and Graves’ disease than in follicular adenomas. J Clin Endocrinol Metab 89:5810, 2004

236. Galofre JC, Davies TF: Microchimerism and thyroid disease. Hot Thyroidology (www.hotthyroidology.com) August 2007

237. Walsh JP, Bremmer AP, Bulsara MK, et al: Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab 90:5309, 2005

238. Pedersen IB, Laurberg P, Knudesen N, et al: Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur J Endocrinol 154:39, 2006

239. Thomas R, Reid RL: Thyroid disease and reproductive failure. Obstet Gynecol 70:789, 1987

240. Bakimer R, Cohen JR, Shoenfeld Y: What really happens to fecundity in autoimmune diseases? Immunol Allergy Clin N Am 14:701, 1994

241. Garber J: Thyroid disorders and reproduction. In: Infertility: A Comprehensive Text. Seibel M (Editor), Stanford, Appleton & Lange, pp 171-185, 1997

242. Krassas GE, Pontikides N, Kaltsas T, et al: Disturbances of menstruation in hypothyroidism. Clin Endocrinol 50:655, 1999

243. Krassas GE: Thyroid disease and female reproduction. Fertil Steril 74:1063, 2000

244. Davis LE, Leveno KJ, Cunningham FG: Hypothyroidism complicating pregnancy. Obstet Gynecol 72:108, 1988

245. Mizgala L, Lao TT, Hannah ME: Hypothyroidism presenting as hypothermia following pre-eclampsia at 23 weeks gestation: case report and review of the literature. Br J Obstet Gynaecol 98:221, 1991

246. Wasserstrum N, Anania CA: Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol 42:353, 1995

247. Casey BM, Dashe JS, Wells E, et al: Subclinical hypothyroidism and pregnancy outcome. Obstet Gynecol 105:239, 2005

248. Idris I, Srinivasan R, Simm A, Page RC: Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol 63:560, 2005

249. Pop VJ, Brouwers EP, Wijnen H, et al: Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation? Int J Obstet Gynaecol 111:925, 2004

250. Blazer S, Moreh-Waterman Y, Miller-Lotan R, et al: Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol 102:232, 2003

251. Montoro M, Collea JV, Frasier SD, Mestman JH: Successful outcome of pregnancy in women with hypothyroidism. Ann Intern Med 94:31, 1981

252. Liu H, Momotani N, Noh JY, et al: Maternal hypothyroidism during early pregnancy and intellectual development of progeny. Arch Intern Med 154:785, 1994

253. Tan TO, Cheng YW, Caughey AB: Are women who are treated for hypothyroidism at risk for pregnancy complications? Am J Obstet Gynecol 194:e1-3, 2006

254. Spong CY (Editorial): Maternal thyroid disorders and preterm birth: another piece of the puzzle? Thyroid 15:349, 2005

255. Brent GA: Maternal hypothyroidism: recognition and management. Thyroid 9: 661, 1999

256.  Arafah BM: Increased need for thyroxine in women with hypothyroidism during estrogen therapy. New Engl J Med 344:1743, 2001

257. Rotondi M, Mazziotti G, Sorvillo F, et al: Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol 151:695, 2004

258. Rotondi M, Precerutti S, Chiovato L: Maternal hypothyroidism during pregnancy: possible preventive strategies. Clin Endocrinol 64:596, 2006

259. Alexander EK, Marqusee E, Lawrence J, et al: timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351:249, 2004

260. Caixas A, Albareda M, Garcia-Patterson A, et al: Postpartum thyroiditis in women with hypothyroidism antedating pregnancy. J Clin Endocrinol Metab 84:4000, 1999

261. McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, et al: Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol 199(2): el-6 Epub April 29, August 2008

262. Dowling ALS, Iannacone EA, Zoeller RT. Maternal hypothyroidism of neuroendocrine-specific protein A messenger ribonucleic acid in the proliferative zone of fetal rat brain cortex. Endocrinology 142:390, 2001

263.  Iskaros J, Pickard M, Evans I, et al. Thyroid hormone receptor gene expression in first trimester human fetal brain. J Clin Endocrinol Metab 85:2620, 2000

264. Liu Y-Y, Tachiki KH, Brent GA: A targeted thyroid hormone receptor  gene dominant-negative mutation (P398H) selectively impairs gene expression in differentiated embryonic stem cells. Endocrinology 143:2664, 2002

265.  Kilby MD, Gittoes N, McCabe C, et al: Expression of thyroid receptor isoform in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol 53:469, 2000

266. Koibuchi N, Iwasaki T: Regulation of brain development by thyroid hormones and its modulation by environmental chemicals. Endocrol J 53:295, 2006

267. Bernal J: Thyroid hormone receptors in brain development and function. Nature Clin Pract 3:249, 2007

268. Porterfield SP, Hendrich CE: The role of thyroid hormones in prenatal and neonatal neurological development: Current perspectives. Endocr Rev 14:94, 1993

269. Smallridge RC, Ladenson PW: Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab 86:2349, 2001

270. Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Maternal thyroid hormones early in pregnancy and fetal brain development. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:225, 2004

271. Lavado-Autric R, Auso E, Garcia-Velasco JV, et al: Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 111:1073, 2003  

272. Zoeller RT: Transplacental thyroxine and fetal brain development. J Clin Invest 111:954, 2003

273. Dubois GM, Sebillot A, Kuiper GG, et al: Deiodinase activity is present in Xenopus laevis during early embryogenesis. Endocrinology 147:4941, 2006

274. Man EB, Jones WS, Holden RH, Mellits ED: Thyroid function in human pregnancy. VIII. Retardation of progeny aged 7 years; relationships to maternal age and maternal thyroid function. Amer J Obstet Gynecol 111:905, 1971

275. Man EB, Brown JF, Serunian SA: Maternal hypothyroidism: Psychoneurological deficits of progeny. Ann Clin Lab Ser 21:227, 1991

276. Mitchell ML, Klein RZ: The sequelae of untreated maternal hypothyroidism. Eur J Endocrinol 151:45, 2004

277. Rovet J: Neurodevelopmental consequences of maternal hypothyroidism during pregnancy (Abstract). Thyroid 14:710, 2004

278. Pop VJ, Kuijpens JL, Van Baar AL, et al: Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in early infancy. Clin Endocrinol 50:149, 1999

279. Pop VJ, Brouwers EP, Vader HL, et al: Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 59:282, 2003

280. Kooistra L, Crawford S, van Baar AL, et al: Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117:161, 2006

281.  Mitchell ML, Klein RZ, Sargent JD, et al: Iodine sufficiency and measurements of thyroid function in maternal hypothyroidism. Clin Endocrinol 58:612, 2003

282. Bleichrodt N, Bjorn MP: A meta-analysis of research on iodine and its relationship to cognitive development. In: The damaged brain of iodine deficiency: cognitive, behavioral, neuromotor, educative aspects (Editor: Stanbury JB). Cognizant Communication Corporation; New York-Sydney-Tokyo, pp 195-200, 1994

283. Vermiglio F, Lo Presti P, Moleti M, et al: Attention deficit and hyperactivity disorders on the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. J Clin Endocrinol Metab 89:6054, 2004

284. Kasatkina EP, Samsonova LN, Ivakhnenko VN, Ibragimova GV, et al: Gestational hypothyroxinemia and cognitive function in offspring. Neurosci Behav Physiol 36:619-624, 2006

285. Bleichrodt N, Escobar del Rey F, Morreale de Escobar G, et al: Iodine deficiency - Implications for mental and psychomotor development in children. In: Iodine and the Brain (Editors: DeLong GR, Robbins G, Condliffe PG). Plenum Press, New York, 269, 1989

286. Vermiglio F, Sidoti M, Finocchiaro MD, et al: Defective neuromotor and cognitive ability in iodine-deficient schoolchildren of an endemic goiter region in Sicily. J Clin Endocrinol Metab 70:379, 1990

287. Fenzi GF, Giusti LF, Aghini-Lombardi F, et al: Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency. J Endocrinol Invest 13:427, 1990

288. Vitti P, Aghini-Lombardi F, Antonangeli L, et al: Mild iodine deficiency in fetal/neonatal life and neuro-psychological performances. Acta Med Austr 19:57, 1992

289. Aghini-Lombardi F, Pinchera A, Antonangeli L, et al: Mild iodine deficiency during fetal/neonatal life and neuropsychological impairment in Tuscany. J Endocrinol Invest 18:57, 1995

290. Tiwari BD, Godbole MM, Chattopadhyay N, et al: Learning disabilities and poor motivation to achieve due to prolonged iodine deficiency. Am J Clin Nutr 63:782, 1996

291. Azizi F, Sarshar A, Nafarabadi M, et al: Impairment of neuromotor and cognitive development in iodine-deficient schoolchildren with normal physical growth. Acta Endocrinol 129:501, 1993

292.  Rotondi M, Caccavale C, Di Serio C, et al: Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism. Thyroid 9:1037, 1999

293. Kamijo K, Saito T, Yachi A, et al: Transient subclinical hypothyroidism in early pregnancy. Endocrinol Japon 37:397, 1990

294. Matsuura N, Konishi J and the transient hypothyroidism study group in Japan: Transient hypothyroidism in infants born to mothers with chronic thyroiditis - A nationwide study of twenty-three cases. Endocrinol Japon 37:369, 1990

295. Becks GP, Burrow GN: Thyroid disease and pregnancy. Med Clin N Amer 75:121, 1991

296. Wang C, Crapo LM: The epidemiology of thyroid disease and implications for screening. Endocrinol Clin N Amer 26:189, 1997

297. LeBeau SO, Mandel SJ: Thyroid disorders during pregnancy. Endocrinol Metab Clin N Am 35:117, 2006

298. Hollowell JG, Staehling NW, Flanders WD, et al: Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489, 2002

299. Marx H, Amin P, Lazarus JH: Hyperthyroidism and pregnancy. Brit Med J 336:663-667, 2008

300. Hershman JM: Hyperthyroidism induced by trophoblastic thyrotropin. Mayo Clin Proc 47:913, 1997

301.  Narasimhan KL, Ghobrial MW, Ruby EB: Hyperthyroidism in the setting of gestational trophoblastic disease. Amer J Med Sci 323:285, 2002

302. Coughlin L, Haddad: Struma ovarii presenting as hyperemesis gravidarum in pregnancy. J Obstet Gynecol 20:310, 2000

303. Ginsberg J, Lewanczuk RZ, Honore LH: Hyperplacentosis: a novel cause of hyperthyroidism. Thyroid 11:393, 2001

304. Mestman JH: Hyperthyroidism in pregnancy. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:267, 2004

305. Mestman JH: Hyperthyroidism in pregnancy. Clin Obstet Gynecol 40:45, 1997

306. Amino N, Tanizawa O, Mori H, et al: Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab 55:108, 1982

307. Kamijo K: TSH-receptor antibodies determined by the first, second and third generation assay and thyroid-stimulating antibody in pregnant patients with Graves’ disease. Endocr J 54:619-624, 2007

308. Millar LK, Wing DA, Leung As, et al: Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946, 1994

309. Davis LE, Lucas MJ, Hankins GD, et al: Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160:63, 1989

310. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al: Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol 54:365, 2001

311. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S: Fetal loss associated with excess of thyroid hormone exposure. JAMA 292:691, 2004

312. Sheffield JS, Cunningham FG: Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 190:211, 2004

313. Smith C, Thomsett, Choong C, et al: Congenital thyrotoxicosis in premature infants. Clin Endocrinol 54:371, 2001

314. Vaidya B, Campbell V, Tripp JH, et al: Premature birth and low birth weight associated with non-autoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol 60:711, 2004

315. Mitsuda N, Tamaki H, Amino N, et al: Risk factors for developmental disorders in infants born to women with Graves' disease. Obstet Gynecol 80:359, 1992

316. Laurberg P, Nygaard B, Glinoer D, et al: Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 139:584, 1998

317. Radetti G, Persani L, Moroder W, et al: Transplacental passage of anti-thyroid auto-antibodies in a pregnant woman with auto-immune thyroid disease. Prenatal Diagnosis 19:468, 1999

318. Peleg D, Cada S, Ben-Ami M: The relationship between maternal serum thyroid-stimulating immunoglobulins and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99:1040, 2002

319. Geva E, Amit A, Lerner-Geva L, Lessing JB: Autoimmunity and reproduction. Fertil Steril 67:599, 1997

320. Jones BM, Kwok JSY, Kung AWC: Changes in cytokine production during pregnancy in patients with Graves’ disease. Thyroid 10:701, 2000

321. Kung AWC, Jones BM: A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. J Clin Endocrinol Metab 83:514, 1998

322.  Kung AWC, Lau KS, Kohn LD: Epitope mapping of TSH receptor-blocking antibodies in Graves’ disease that appear during pregnancy. J Clin Endocrinol Metab 86:3647, 2001

323. Amino N, Izumi Y, Hidaka Y, et al: No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves’ disease. J Clin Endocrinol Metab 88:5871, 2003

324. Tagami T, Hagiwara H, Kimura T, Usui T, Shimatsu A, Naruse M: The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves’ disease. Thyroid 17:767-772, 2007

325. Gola S, Doga M, Mazziotti G, Bonadonna S, Giustina A: Development of Graves’ hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto’s hypothyroidism. J Endocrinol Invest 29:288, 2006

326. Mandel SJ, Cooper DS: The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86:2354, 2001

327. Cooper DS: Antithyroid drugs. N Engl J Med 352:905, 2005

328. Wing DA, Millar LK, Koonings PP, et al: A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170:90, 1994

329. Mandel SJ, Brent GA, Larsen PR: Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 4:129, 1994

330. Marchant B, Brownlie BEW, Hart DM, et al: The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 45:1187, 1977

331. Skellern CG, Knight BI, Otter M: The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. Brit J Clin Pharmacol 9:145, 1980

332. Gardner DF, Cruikshank DP, Hays PM, Cooper DS: Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: Correlation of maternal PTU concentration with cord serum thyroid function tests. J Clin Endocrinol Metab 62:217, 1986

333. Cheron RG, Kaplan MM, Larsen PR, et al: Neonatal thyroid function after propylthiouracil therapy for maternal Graves’ disease. N Engl J Med 304:525, 1981

334. Mortimer R, Cannell GR, Addison R, et al: Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 82:3099, 1997

335. Momotani N, Noh JY, Ishikawa N, Ito K: Effects of propylthiouracil (PTU) and methimazole (MMI) on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab 82:3633, 1997

336.        Klasco RK (Edition 2005); REPROTOX database Greenwood Village, CO: Thomson Micromedex. Available at: http://www.thomsonhc.com

337. Redmond GP: Propranolol and fetal growth retardation. Semin Perinatol 6:142, 1982

338. Herbst AL, Selenkow HA: Hyperthyroidism during pregnancy. N Engl J Med 273:627, 1965

339. Momotani N, Hisaoka T, Noh J, et al: Effects of iodine on thyroid status of fetus versus mother in treatment of Graves’ disease complicated by pregnancy. J Clin Endocrinol Metab 75:738, 1992

340. Zanzonico PB: Radiation dose to patients and relatives incident to 131-I therapy. Thyroid 7:199, 1997

341. Berg GE, Nystrom EH, Jacobsson L, et al: Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med 39:2194, 1998

342. Lowe SA: Diagnostic radiography in pregnancy: risks and reality. Aust NZ J Obstet Gynaecol 44:191, 2004

343. Levinson G: Anesthesia for surgery during pregnancy. In: Hughes SC, Levinson G, Rosen MA (Eds). Shnider & Levinson's anesthesia for obstetrics, 4th ed. Philadelphia; Lippincott Williams & Wilkins; pp 249-265, 2002

344. Low LC, Lang J, Alexander WD: Excretion of carbimazole and propylthiouracil in breast milk. Lancet 2:1011, 1979

345. Kampmann JP, Johansen K, Hansen JM, Helweg J: Propylthiouracil in human milk. Lancet 1:736, 1980

346. Tegler L, Lindstrom B: Antithyroid drugs in milk. Lancet 2:591, 1980

347. Lamberg BA, Ikonen E, Teramo K, et al: Treatment of maternal hyperthyroidism with antithyroid agents and changes in thyrotrophin and thyroxin in the newborn. Acta Endocrinol 97:186, 1981

348. Lamberg BA, Ikonen E, Osterlund K, et al: Antithyroid drug treatment of maternal hyperthyroidism during lactation. Clin Endocrinol 21:81, 1984

349. Azizi F, Khoshniat M, Bahrainian M, Hedayati M: Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 85:3233, 2000

350. Mestman JH: Hyperthyroidism in pregnancy. Endocrinol Clin N Amer 27:127, 1998

351. Azizi F: Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study. J Endocrinol Invest 26:301-304, 2003

352. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM: The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies. Endocrine Rev 19:673, 1998

353. Matsuura N, Harada S, Ohyama Y, et al: The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves’ disease. Ped Res 42:214, 1997

354. Weetman AP: Graves’ disease. New Eng J Med 343:1236, 2000

355. Nachum Z, Rakover Y, Weiner E, Shalev E: Graves’ disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 189:159, 2003

356. Polak M: Hyperthyroidism in early infancy: Pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid 8:1171, 1998

357. Porreco RP, Bloch CA: Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstet Gynecol 76:509, 1990

358. Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. New Engl J Med 324:532, 1991

359. Wallace C, Couch R, Ginsberg J: Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. Thyroid 5:125, 1995

360. Skuza KA, Sills IN, Stene M, Rapaport R: Prediction of neonatal hyperthyroidism in infants born to mothers with Graves’ disease. J Pediat 128:264, 1996

361. Polak M, Leger J, Luton D, et al: Fetal cord blood sampling in the diagnosis and treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother producing thyroid stimulating antibodies. Ann Endocrinol (Paris) 58:338, 1997

362. Momotani N, Noh J, Oyanagi H, et al: Antithyroid drug therapy for Graves’ disease during pregnancy: optimal regimen for fetal thyroid status. N Eng J Med 315:24, 1986

363. Azizi F, Khamseh ME, Bahreynian M, Hedayati M: Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 25:586, 2002

364. Calderwood C, Williams H, Campbell IW, et al: Cordocentesis to predict fetal outcome after administration of radio-active iodine for Graves’ disease. J Obstet Gynaecol 22:217, 2002

365. Wenstrom KD, Weiner CP, Williamson RA, Grant SS: Prenatal diagnosis of fetal hyperthyroidism using funipuncture. Obstet Gynecol 76:513, 1990

366. Azizi F, Hedayati M: Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 25:493, 2002

367. Casey BM, Dashe JS, Wells CE, et al: Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 107:337, 2006

368. Davidson KM, Richards DS, Schatz DA, Fisher DA: Successful in utero treatment of fetal goiter and hypothyroidism. New Eng J Med 324:543, 1991

369. Heckel S, Favre R, Schlienger JL, Soskin P: Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves’ disease. Fetal Diagn Ther 12:54, 1997

370. Ochoa-Maya MR, Frates MC, Lee-Parritz A, Seely EW: Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves’ hyperthyroidism. Thyroid 9:1111, 1999

371. Volumenie JL, Polak M, Guibourdenche J, et al: Management of fetal goitres: a report of eleven cases in a single perinatal unit. Prenat Diagn 20:799, 2000

372. Polak M, Le Gac I, Vuillard E, et al: Fetal and neonatal thyroid function in relation to maternal Graves’ disease. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:289, 2004

373. Luton D, Le Gac I, Vuillard E, et al: Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90:6093, 2005 

374. Gallagher MP, Schachner HC, Levine LS, et al: Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves’ disease during pregnancy: a problem revisited. J Pediatr 139:896, 2001

375. Luton D, Le Gac I, Noel M, Guibourdenche J, Polak M: Thyroid function during pregnancy in women with past Graves’ disease. Brit J Obstet Gynaecol 112:1565, 2005 

376. Chan GW, Mandel SJ: Therapy insight: management of Graves’ disease during pregnancy. Nature Clin Pract Endocrinol Metab 3:470-478, 2007

377. Frieden IJ: Aplasia cutis congenita: a clinical review and proposal for classification. Acta Dermatol 14:646, 1986

378. Clementi M, Di Gianantonio E, Pelo E, et al: Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83:43, 1999

379. Johnsson E, Larsson G, Ljunggren M: Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 350:1520, 1997

380. Bournaud C, Orgiazzi J: Embryopathies et anti-thyroïdiens. Ann Endocrinol (Paris) 64:366, 2003

381. Di Gianantonio E, Schaefer C, Mastroiacovo P, et al: Adverse effects of prenatal methimazole exposure. Teratology 64:262, 2001

382. Iwayama H, Hosono H, Yamamoto H, Oshiro M, Ueda N: Aplasia Cutis Congenita with skull defect in a monozygotic twin after exposure to methimazole in utero. Birth Defects Res Clin Molec Teratol 79: 680-684, 2007

383. Zakarija M, Garcia A, McKenzie JM: Studies on multiple thyroid cell membrane-directed antibodies in Graves’ disease. J Clin Endocrinol Metab 76:1885, 1985

384. Tamaki H, Amino N, Aozasa M, et al: Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. Am J Perinatol 5:152, 1988

385. Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D: Congenital hyperthyroidism: the fetus as a patient. Horm Res 65:235, 2006

386. Mandel SH, Hanna CE, LaFranchi SH: Neonatal hypopituitarism associated with maternal thyrotoxicosis. J Pediat Endocrinol 3:189, 1989

387. Kempers MJ, van Tijn DA, van Trotsenburg AS, et al: Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 88:5851, 2003

388. Kempers MJ, Van Trotsenburg AS, Van Rijn RR, Smets AM, et al: Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves’ disease. J Clin Endocrinol Metab 92:2984-2991, 2007

389. Stagnaro-Green A: Postpartum thyroiditis. J Clin Endocrinol Metab 87:4042, 2002

390. Amino N, Tada H, Hidaka Y, Izumi Y: Postpartum autoimmune thyroid syndrome. Endocr J 47:645, 2000

391. Sakaihara M, Yamada H, Kato EH, et al: Postpartum thyroid dysfunction in women with normal thyroid function during pregnancy. Clin Endocrinol 53:487, 2000

392. Stagnaro-Green A: Postpartum thyroiditis. In: Best Practice & Research in Clinical Endocrinology and Metabolism: The Thyroid and Pregnancy (Editor: Glinoer D) 18:303, 2004

393. Premawardhana LD, Parkes AB, Ammari F, et al: Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 85:71, 2000

394. Premawardhana LD, Parkes AB, John R, Harris B, Lazarus JH: Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 14:610, 2004  

395. Hidaka Y, Tamaki H, Iwatani Y, et al: Prediction of post-partum Graves’ thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy. Clin Endocrinol 41:15, 1994

396. Nakagawa Y, Mori K, Hoshikawa S, Yamamoto M, et al: Postpartum recurrence of Graves’ hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. Clin Endocrinol 57:467, 2002

397. Benhaim Rochester D, Davies TF: Increased risk of Graves’ disease after pregnancy. Thyroid 15:1287, 2005

398. Leylek OA, Cetin A, Toyaksi M, Erselcan T: Hyperthyroidism in hyperemesis gravidarum. Int J Gynaecol Obstet 55:33, 1996

399. Tanaka S, Yamada H, Kato EH, et al: Gestational transient hyperthyroxinaemia (GTH): screening for thyroid function in 23163 pregnant women using dried blood spots. Clin Endocrinol 49:325, 1998

400. Yeo CP, Hsu Chin Khoo D, Hsi Ko Eng P, et al: Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol 55:391, 2001

401. Ramsey PS, Ramin KD: 34-year-old pregnant woman with nausea and vomiting. May Clin Proc 75:1317, 2000

402. Utiger RD: Some women with hyperemesis gravidarum have transient hyperthyroidism. Clinical Thyroidology 14:56, 2002

403. Anselmo J, Kay T, Dennis K, et al: Resistance to thyroid hormone does not abrogate the transient thyrotoxicosis associated with gestation: report of a case. J Clin Endocrinol Metab 86:4273, 2001

404. Grün JP, Meuris S, De Nayer P, Glinoer D: The thyrotropic role of human chorionic gonadotropin (hCG) in the early stages of twin (versus single) pregnancy. Clin Endocrinol 46:719, 1997

405. Kimura M, Amino N, Tamaki H, et al: Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol 38:345, 1993

406. Tsuruta E, Tada H, Tamaki H, et al: Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 80:350, 1995

407. Talbot JA, Lambert A, Anobile CJ, et al: The nature of human chorionic gonadotrophin glycoforms in gestational thyrotoxicosis. Clin Endocrinol 55:33, 2001

408. Vassart G, Dumont JE: The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596, 1992

409. Garcia-Campayo V, Kumar TR, Boime I: Thyrotropin, follitropin, and chorionic gonadotropin expressed as a single multifunctional unit reveal remarkable permissiveness in receptor-ligand interactions. Endocrinology 143:3773, 2002

410. Rodien P, Brémont C, Raffin Sanson M-L, et al: Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. New Engl J Med 339:1823, 1998

411. Rodien P: Un récepteur de la TSH hypersensible à l’hCG responsable d’une hyperthyroïdie gestationelle récidivante et familiale. Reproduction Humaine & Hormones 14:655, 2001

412. Rodien P, Jordan N, Lefèvre A, et al: Abnormal stimulation of the thyrotrophin receptor during gestation. Hum Reprod Update 10:95, 2004

413. Deruelle P, Dufour P, Subtil D, et al: Hyperemesis in the first trimester of pregnancy: role of biological hyperthyroidism and fetal sex. Gynecol Obstet Fertil 30:204, 2002

414. Panesar NS, Li C-Y, Rogers MS: Are thyroid hormones or hCG responsible for hyperemesis gravidarum? A matched paired study in pregnant Chinese women. Acta Obstet Gynecol Scand 80:519, 2001   

415. Chiniwala NU, Woolf PD, Bruno CP, Kaur S, et al: Thyroid storm caused by a partial hydatidiform mole. Thyroid 18:479-481, 2008

416. Rosen IB, Walfish PG, Nikore V: Pregnancy and surgical thyroid disease. Surgery 98:1135, 1985

417. Hamburger JI: Thyroid nodules in pregnancy. Thyroid 2:165, 1992

418. Struve C, Haupt S, Ohlen S: Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 3:7, 1993

419. Kung AWC, Chau MT, Lao TT, Tam SCF, Low LCK: The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 87:1010, 2002

420. Choe W, McDougall IR: Thyroid cancer in pregnant women: diagnosis and therapeutic management. Thyroid 4:433, 1994

421. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418, 1994

422. Moosa M, Mazzaferri EL: Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 82:2862, 1997

423. Glinoer D: Nodule et cancer thyroïdiens chez la femme enceinte. Annales d’Endocrinologie (Paris) 58:263, 1997

424. Rosen IB, Korman M, Walfish PG: Thyroid nodular disease in pregnancy: current diagnosis and management. Clin Obstet Gynecol 40:81, 1997

425. Herzon FS, Morris DM, Segal MN, et al: Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 120:1191, 1994

426. Sam S, Molitch ME: Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinol Metab Clin N Am 32:337, 2003

427. Vini L, Hyer S, Pratt B, Harmer C: Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 140:404, 1999

428. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA: Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501, 1988

429. Doherty C, Shindo M, Rice D, et al: Management of thyroid nodules during pregnancy. Laryngoscope 105:251, 1995

430. Tan GH et al: Management of thyroid nodules in pregnancy. Arch Int Med 156:2317, 1996

431. Yasmeen S, Cress R, Romano PS, et al: Thyroid cancer in pregnancy. Int J Gynaecol Obstet 91:15, 2005

432. Rosario PW, Barroso AL, Purisch S: The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of disease. Thyroid 17:1175-1176, 2007 

433. Leboeuf R, Emerick LE, Martorella AJ, Tuttle RM: Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid 17:543-547, 2007

434. Stagnaro-Green A: Can a high-risk case-finding approach identify all women with thyroid dysfunction during pregnancy. Nature Clin Pract Endocrinol Metab 3:216, 2007

435. Lazarus JH, Premawardhana LD: Screening for thyroid disorders in pregnancy. J Clin Pathol 58:449, 2005

 

436. Dosiou C, Sanders GD, Araki SS, Crapo LM: Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 158:841-851, 2008

 

437. American College of Obstetricians & Gynecologists. ACOG practice bulletin (N°37): Clinical management guidelines for obstetricians-gynecologists. Obstet Gynecol 100:387, 2002

 

438. Ladenson PW, Singer PA, Ain KB, et al: American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 160:1573, 2000

 

439. Surks MI, Ortiz E, Daniels GH, et al: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228, 2004

 

440. Gharib H, Tuttle MR, Baskin HJ, et al: Consensus statement: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 90:581, 2005

 

441. ACOG News release: Routine thyroid screening not recommended for pregnant women. October 2007. www.acog.org/from_home/publications/press_releases/nr10-01-07-1.cfm

442. Surks MI: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90:586, 2005 

 

443. Davies TF (Editorial): Time for the American Thyroid Association to lead on thyroid screening in pregnancy. Thyroid 17:697-698, 2007 

 

444. Rinaldi MD, Stagnaro-Green AS: Thyroid disease and pregnancy: degrees of knowledge. Thyroid 747-753, 2007

 

445. Haddow JE, McClain MR, Palomaki GE, et al: Screening for thyroid disorders during pregnancy: results of a survey in Maine. Am J Obstet Gynecol 194:471, 2006

 

446. Vaidya B, Anthony S, Bilous M, et al: Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 92:203, 2007 

 

447. Brent GA: Diagnosing thyroid dysfunction in pregnant women: is case finding enough (Editorial)? J Clin Endocrinol Metab 92:39, 2007